Investment in engineering team signals Nucleus' commitment to innovation and putting comprehensive health data in the hands of users NEW…
FREMONT, Calif., Feb. 25, 2025 /PRNewswire/ -- Ultima Genomics, Inc., developer of the UG100™ next-generation sequencing (NGS) platform, today announced expanded…
TERN-701 CARDINAL study progressing well; dose expansion expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25…
PLANO, Texas, Feb. 24, 2025 /PRNewswire/ -- StaffDNA, the innovative digital marketplace that improves the healthcare hiring ecosystem, has recently…
Company expands multiomics portfolio with new roadmap technologies spanning genomics, spatial, single cell, CRISPR, and methylation, as well as a…
Commercial launch of UG 100 Solaris which includes new chemistry, software, and simplified workflows for the UG 100 sequencing platform, now…
Vivos announces immediate expansion of its new alliance model into two additional Colorado locations as initial reports show sleep apnea…
Data confirms Versamune® HPV has potential as a broadly effective treatment of HPV16-associated cancers – Initiation of Phase 3 trial in…
The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component SALT LAKE…
Longstanding partners bring together end-to-end workflows and leading CRISPRPerturb-seq technologies setting a standard for single-cell studies and enabling a 5billion…